International Journal of Cancer Management

Published by: Kowsar

Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines

Mahdieh Shokrollahi Barough 1 , 3 , Hadi Hasanzadeh 2 , Mehdi Barati 1 , 3 , Fatemeh Pak 1 , Parviz Kokhaei 1 , 4 , 5 , * and Mostafa Rezaei-Tavirani 6
Authors Information
1 Cancer Research Center, Department of Immunology, Semnan University of Medical Sciences, Semnan, IR Iran
2 Department of Medical Physics, Cancer Research Center, Semnan University of Medical Sciences, Semnan, IR Iran
3 Student’s Research Committee, Semnan University of Medical Sciences, Semnan, IR Iran
4 Immunology Research Center, Iran University of Medical Sciences, Tehran, IR Iran
5 Department of Oncology-Pathology, Cancer Center Karolinska (CCK), Solna and Karolinska Institute, Immune and Gene Therapy Laboratory, Karolinska University Hospital, Stockholm, Sweden
6 Proteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: December 28, 2015, 8 (6); e4193
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: October 1, 2015
  • Accepted: November 21, 2015
  • DOI: 10.17795/ijcp-4193

To Cite: Shokrollahi Barough M, Hasanzadeh H, Barati M, Pak F, Kokhaei P, et al. Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines, Int J Cancer Manag. 2015 ; 8(6):e4193. doi: 10.17795/ijcp-4193.

Copyright © 2015, Iranian Journal of Cancer Prevention.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Wang WL, Porter W, Burghardt R, Safe SH. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Carcinogenesis. 1997; 18(5): 925-33[PubMed]
  • 2. Shafie SM, Grantham FH. Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J Natl Cancer Inst. 1981; 67(1): 51-6[PubMed]
  • 3. Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, et al. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer (Auckl). 2010; 4: 35-41[PubMed]
  • 4. Price JE, Polyzos A, Zhang RD, Daniels LM. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 1990; 50(3): 717-21[PubMed]
  • 5. Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis. 2010; 32(1-2): 35-48[DOI][PubMed]
  • 6. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005; 5(10): 773-85[DOI][PubMed]
  • 7. Rivera E, Gomez H. Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone. Breast Cancer Res. 2010; 12 Suppl 2[DOI][PubMed]
  • 8. Breast cancer and endocrine therapy 2014. 2014;
  • 9. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006; 10(6): 515-27[DOI][PubMed]
  • 10. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005; 5(3): 231-7[DOI][PubMed]
  • 11. Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011; 30: 87[DOI][PubMed]
  • 12. Signore M, Ricci-Vitiani L, De Maria R. Targeting apoptosis pathways in cancer stem cells. Cancer Lett. 2013; 332(2): 374-82[DOI][PubMed]
  • 13. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144(5): 646-74[DOI][PubMed]
  • 14. Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol. 1997; 25(1): 82-8[PubMed]
  • 15. Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res. 2007; 13(24): 7271-9[DOI][PubMed]
  • 16. Shan X, Wang D, Chen J, Xiao X, Jiang Y, Wang Y, et al. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer. J Comput Assist Tomogr. 2013; 37(1): 22-8[DOI][PubMed]
  • 17. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140(6): 883-99[DOI][PubMed]
  • 18. Gentile M, Latonen L, Laiho M. Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses. Nucleic Acids Res. 2003; 31(16): 4779-90[PubMed]
  • 19. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med. 2006; 12(9): 440-50[DOI][PubMed]
  • 20. Artiukhov VG, Zemchenkova OV, Basharina OV, Riazantsev SV, Pashkov MV. [Apoptosis and necrosis of lymphocytes induced by UV-radiation in the presence of autological plasma]. Tsitologiia. 2014; 56(1): 77-83[PubMed]
  • 21. Golstein P, Ojcius DM, Young JD. Cell death mechanisms and the immune system. Immunol Rev. 1991; 121: 29-65[PubMed]
  • 22. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010; 140(6): 798-804[DOI][PubMed]
  • 23. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem. 1997; 272(41): 25783-6[PubMed]
  • 24. Mori S, Jewett A, Murakami-Mori K, Cavalcanti M, Bonavida B. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol Immunother. 1997; 44(5): 282-90[PubMed]
  • 25. Chatterjee M, Wu S. Involvement of Fas receptor and not tumor necrosis factor-alpha receptor in ultraviolet-induced activation of acid sphingomyelinase. Mol Carcinog. 2001; 30(1): 47-55[PubMed]
  • 26. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol. 1998; 140(1): 171-82[PubMed]
  • 27. Wu S, Loke HN, Rehemtulla A. Ultraviolet radiation-induced apoptosis is mediated by Daxx. Neoplasia. 2002; 4(6): 486-92[DOI][PubMed]
  • 28. Mor G, Sapi E, Abrahams VM, Rutherford T, Song J, Hao XY, et al. Interaction of the estrogen receptors with the Fas ligand promoter in human monocytes. J Immunol. 2003; 170(1): 114-22[PubMed]
  • 29. O'Connell J, Bennett MW, O'Sullivan GC, O'Callaghan J, Collins JK, Shanahan F. Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege. Clin Diagn Lab Immunol. 1999; 6(4): 457-63[PubMed]
  • 30. Rahman M, Davis SR, Pumphrey JG, Bao J, Nau MM, Meltzer PS, et al. TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype. Breast Cancer Res Treat. 2009; 113(2): 217-30[DOI][PubMed]
  • 31. Tu CC, Kumar VB, Day CH, Kuo WW, Yeh SP, Chen RJ, et al. Estrogen receptor alpha (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins. J Mol Endocrinol. 2013; 51(1): 203-12[DOI][PubMed]
  • 32. Pollheimer MJ, Kornprat P, Lindtner RA, Harbaum L, Schlemmer A, Rehak P, et al. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum Pathol. 2010; 41(12): 1749-57[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments